Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Open Label Study of AMDX-2011P as a Retinal Tracer in Participants With Primary Open Angle Glaucoma
Conditions
Interventions
AMDX-2011P
Locations
3
United States
Associated Retina Consultants
Phoenix, Arizona, United States
Global Research Management
Glendale, California, United States
Eye Research Foundation
Newport Beach, California, United States
Start Date
December 7, 2023
Primary Completion Date
November 1, 2024
Completion Date
February 1, 2025
Last Updated
July 30, 2024
NCT07390890
NCT07358650
NCT05902871
NCT07076303
NCT06865144
NCT05564091
Lead Sponsor
Amydis Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions